VigilaMed Logo

Crisis Remediation

Transform FDA 483s and Warning Letters into compliance excellence.

Six Sigma CAPA Expert
FDA 483 Response
100% Success Rate

The Challenge

Common pain points that prevent medical device manufacturers from achieving sustainable compliance.

FDA 483 Response

Urgent need to respond to FDA observations within 15 days, with limited time to implement effective fixes.

Root Cause Unknown

Surface-level fixes that don't address underlying systemic issues, leading to repeat findings.

Warning Letter Risk

Escalation to Warning Letter status threatens market access and regulatory standing.

The VigilaMed Solution

Six Sigma CAPA Methodology

We use proven Six Sigma methodologies to identify root causes and implement permanent solutions. No band-aids—only systemic fixes.

Manufacturing-First Methodology: Our structured approach ensures FDA-acceptable responses that demonstrate genuine improvement, not just compliance theater.

VigilaMed QARA Consultancy Logo

What You Get

Tangible deliverables that deliver immediate value and long-term compliance.

  • FDA 483 Response Document
  • Root Cause Analysis Report
  • CAPA Implementation Plan
  • Effectiveness Verification Protocol
  • Follow-up Audit Preparation

Frequently Asked Questions

Ready to secure your compliance?

Schedule a consultation to discuss your specific compliance needs and how we can help you achieve audit-ready excellence.

VigilaMed

Regulatory Excellence for Device Manufacturers. Elite Quality & Regulatory consultancy specializing in ISO 13485, FDA compliance, and medical device manufacturing excellence.

ISO 13485:2016 Lead AuditorFDA 21 CFR Part 820 ExpertSix Sigma Yellow Belt10+ Years Manufacturing

© 2026 VigilaMed Ltd. All rights reserved. Serving Class I, II, and III device manufacturers across UK, EU, and US markets.